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Objectives: PVI is the preferred initial revasculariza-
tion strategy at many centers in patients with critical limb
ischemia (CLI). Using a multicenter, regional database we
sought to determine if previous failed ipsilateral, infraingui-
nal PVI (iiPVI) portends worsened outcomes after subse-
quent lower extremity bypass (LEB) in patients with CLI.
Methods: This is a retrospective cohort analysis of the
Vascular Study Group of New England (VS GNE) database of
infrainguinal lower extremity bypass for CLI (2003-2008).
Study endpoints were major amputation, graft occlusion and
mortality rates at one year, and in-hospital major adverse events
(MAE). Outcomes were determined using Kaplan-Meier analy-
sis and Cox Proportional-Hazard multivariate regression.
Results: Of 1, 153 patients who underwent LEB for
CLI, 71 (6.2%) had a prior failed iiPVI. One year mortality
and in-hospital MAE did not differ between the groups.
Patients undergoing prior iiPVI had significantly higher
rates of graft occlusion and amputation at one year (Table).
Multivariate predictors of 1-yr LEB occlusion were prior
iiPVI (HR 1.8; CI 1.1-2.9), arm vein conduit (HR 1.8; CI
1.1-2.6), and tibial outflow (HR 2.0; CI 1.4-2.9). Multi-
variate predictors of 1-yr major amputation were iiPVI (HR
2.0; CI 1.0-3.7), dialysis (HR 4.2; 2.6-6.6), prior ipsilateral
bypass (HR 1.7; CI 1.1-2.8), tibial outflow (HR 1.9; CI
1.3-2.9), and tissue loss (HR 1.7; CI 1.1-2.7).
Conclusions: Failed iiPVI is an important predictor of
both graft occlusion and major amputation after LEB in CLI
patients.
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Occlusion (1-yr) 16% 31% 0.01 16% 24% 0.08
Amputation (1-yr) 14% 23% 0.08 14% 21% 0.03
Death (1-yr) 10% 13% 0.97 10% 10% 0.95
MAE (in-hospital) 29% 32% 0.5 29% 29% 0.91
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SS15.
Sustained 5 Years Performance Analysis of Sequential Com-
pression Biomechanical Device (SCBD) in Critical Limb
Ischaemia (CLI) Patients with Un-reconstructable Periph-
eral Vascular Disease (PVD) vs Primary Amputation in a
Tertiary Referral Vascular Centre With Quality of Time
Without the Symptoms or Toxicity of the Disease
(QTWiST)
Sherif Sultan, Nader Hamada, Wael Tawfick, Anne Fahy,
Niamh Hynes. Vascular & Endovascular Surgery, Western
Vascular Institute, Galway, IrelandObjectives: Our aim was assess the clinical efficacy and
economic viability of a SCBD programme for CLI. Primary
endpoints were sustained clinical improvement and ampu-
tation free survival. Secondary endpoints were Q-TWiST
and cost per QALY.
Methods: From 2004 to 2009, we assessed 4538 pa-
tients with PVD. Of which 707 had CLI and 518 had
intervention, while 189 were not candidates for any inter-
vention. Only 170 patients had joined the SCBD pro-
gramme for three months at three hours bi-daily. We
matched controlled 75 primary amputations. All patients
were Rutherford category 4 or more. The median fol-
low-up was 13 months with average of 18.3 months.
Results: Sustained clinical improvement was reported in
68% of patients. Sustained hemodynamic improvement were
notedwith;Mean toe pressure increased from39.9mmHg to
55.42mmHgwith mean difference in Toe Pressure of 15.49
mmHg p 0.0001; andMean Popliteal flow increased from
35.44cm/sec to 55.91cm/sec with Mean Difference in Pop-
liteal Flow of 20.47cm/sec p 0.0001. Thirty-day mortality
was 0.6%.Mean Amputation-free survival rate was 18months
with limb salvage rate at 5years of 94%. Freedom fromMACE
at 5 Years was 62.5%. All cause survival was 68.4%% at 5 years.
Estimatedmedian Inpatient/Total cost of managing a prima-
ry-amputation patient is €29, 815 compared to €3985 for
SCBD.We treated170patientswith artassist at a cost of €681,
965. However, primary amputation for 75 patients had cost
€2, 236, 125 with poor QALY/QTWiST.
Conclusions: SCBD Improves Quality of Life at a
Community Level. This study provides larger scale evi-
dence that SCBD therapy is a cost-effective and clinically
efficacious solution as it has Superior Limb Salvage, Ame-
liorated Amputation Free Survival, Reduced Length of
Hospital Stay and Provided Rapid Relief of Rest Pain
without any Intervention in Patients with Limited Life
Expectancy.
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A Comparison of Endovascular Revascularization and
Bypass in Regards to Healing Rates of Ischemic
Wounds
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Georgetown University Hospital, Washington, DC
Objectives: Compare wound healing after endovascu-
lar therapy (EV) or lower extremity bypass (LEB) to inves-
tigate equivalence based on tissue results and wound char-
acteristics.
Methods: A retrospective review analyzed 290 patients
undergoing revascularization for an ischemic wound from
January 2004 to December 2008. Inclusion required com-
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Analysis of degree and rate of healing was performed based
on initial wound size.
Results:The study included142LEBand148EVpatients
with similar age (EV 70, LEB 71), diabetes mellitus (EV 58%,
LEB 41%), and chronic renal failure (EV 24%, LEB 21%). EV
procedures (balloon angioplasty n 20, stent deployment n
82, atherectomy n  30, and cryoplasty n  10) treated SFA
(30%), popliteal (19%), and tibial (51%) lesions with 2.8 lesions
treated per patient. LEB included 98 vein grafts and 44 using
PTFE with a distal vein patch. Target arteries included BK pop-
liteal (n 14), anterior tibial (n 46), posterior tibial (n 41),
and peroneal (n 41). Therewas no difference in average initial
wound size (EV14.1mm,LEB14.6mm)with complete healing
in 76% after LEB and 41% after EV (p 0.013). This difference
was significant in larger wounds (Group C) with complete heal-
ing in 70%LEB and 27%EV (p 0.02). A shortermedian time
to healing was noted after bypass; LEB 98 days, EV 132 days
(p 0.048). There were 40 amputations; EV 30 (20% total, 8%
major), and LEB 10 (7% total, 2.8%major).
Conclusions: This comparison of wound healing after
bypass or endovascular revascularization demonstrates
more complete healing and a faster rate of healing after
open bypass for larger wounds ( 2 cm). Initial wound size
should be a consideration in choosing the method of
revascularization for ischemic wounds.
Healing based on initial wound size
Group LEB EV
A (0-5 mm) 81.1% 94 days 53.8% 105 days
B (5.1 – 20 mm) 76.2% 102 days 41.7% 128 days
C ( 20 mm) * 70.2% 115 days 27.1% 164 days
*p  0.01
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Video Presentation
Popliteal to Dorsalis Pedis Translocated Vein Graft
Frank W. LoGerfo1, Frank B. Pomposelli1, Allen Hamdan1,
Bernadette Aulivola2. 1Beth Israel Deaconess Medical Center,
Boston,MA; 2Loyola UniversityMedical center, Chicago, IL
Background: Autogenous vein bypass grafts to the dor-
salis pedis artery are an essential surgical skill in the care of
patients with foot ulcers associated with Diabetes Mellitus.
Technical Description: This is a video showing the key
steps in the performance of a popliteal to dorsalis pedis translo-
cated vein graft demonstrating angioscopically verified valve lysis.
Author Disclosures: B. Aulivola: Nothing to disclose; A.
Hamdan: Nothing to disclose; F. W. LoGerfo: Nothing
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Vacuum-Assisted Closure (VAC) Therapy for the Treat-
ment of Deep (Szilagyi Grade III-Infection) in the Groin
Ramesh Tripathi1, Kiriakos Ktenidis2. 1Vascular & Endo-
vascular Surgery, Indraprastha Apollo Hospital, New
Delhi, Hungary; 2Aristotle University, Thessaloniki, Greece
Objectives: To evaluate the benefit of vacuum-assisted
closure (VAC) therapy for the treatment of deep alloplastic
graft infections (Szilagyi Grade III-Infection) in the groin.
Methods: From 2000 to 2009, 72 deep inguinal infec-
tions involving native as well as synthetic graft or patch
material. There were 29 early graft infections ( 30 days
after implantation) and 43 late infections. 55 cases involved
non-native grafts/patches (26 PTFE grafts, 24 Dacron
grafts, 5 Vascuguard Bovine Pericardial patches). All pa-
tients were treated with multiple wound debridements,
graft salvage, sartorius myoplasty, IV antibiotics and VAC
dressings till thru-surface healing was achieved. Exclusion
criteria were an alloplastic graft infection with proximal
expansion above the inguinal ligament, blood culture pos-
itive septicaemia or septic anastomotic herald or overt
bleeding.
Results: At 9 months, overall, graft/patch salvage was
achieved in 70/72 (97.2%) patients. In the non-native
group, vein or synthetic graft preservation without revision
was achieved in 48/55 (82.27%) patients. The mean dura-
tion of VAC treatment was 16  7.7 days, postoperative
mean hospital stay was 25.3 8.5 days. In 23 (31.9%) cases
a secondary closure of the wound could be achieved. In 49
cases wound healing was achieved by meshed split skin
grafting. Mean wound healing time for all wounds was
24.3 12.5 days. Mean postoperative follow-up was 4.3
3.5 years with no procedure-related mortality. Specific
complications during VAC-therapy were wound fluid re-
tention in 2 cases and an increased need for analgesics in 12
patients.
Conclusions: Even in the presence of synthetic vascu-
lar graft material, negative pressure therapy can greatly
simplify challenging wound-healing problems. Our long-
term experience demonstrates the safety and effectiveness
of VAC-therapy for the treatment of deep graft infections.
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Tripathi: Nothing to disclose.
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Objectives: Reducing rehospitalization rates has been
proposed to improve care, reduce costs, and as a pay-for-
performance criterion. Recent review of Medicare claims
